Fig. 2From: Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumorsKaplan Meier curves comparing progression free survival by FATSI status (P for logrank, 0.03). X-axis corresponds to progression free survival in months and Y-axis corresponds to survival probability. FATSI negative patients’ curve in blue; FATSI positives in red. + = censoredBack to article page